Metrics to compare | 237690 | Sector Sector - Average of metrics from a broad group of related Healthcare sector companies | Relationship Relationship237690PeersSector | |
|---|---|---|---|---|
P/E Ratio | 26.9x | 8.0x | −0.4x | |
PEG Ratio | 0.24 | 0.04 | 0.00 | |
Price/Book | 3.3x | 0.9x | 2.6x | |
Price / LTM Sales | 5.4x | 0.7x | 3.1x | |
Upside (Analyst Target) | 91.9% | 51.3% | 49.6% | |
Fair Value Upside | Unlock | 16.6% | 7.1% | Unlock |
ST Pharm Co.,Ltd., provides manufacturing services for active pharmaceutical ingredient and intermediate. The company offers small molecule and generics, an ingredient for treating viral infections; oligonucleotide based products, such as siRNA/microRNA, antisense, aptamer, decoys, and other novel oligos; monomer; and mRNA for vaccines and therapeutics. It also offers pre-clinical and bioanalytical research and development solutions. The company was formerly known as Samchully Pharmaceutical Company., Ltd. ST Pharm Co. Ltd. was founded in 1983 and is headquartered in Siheung-si, South Korea.